Tuesday, March 15, 2022
Evangelos J Giamarellos-Bourboulis - National and Kapodistrian University of Athens
Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial
